New 3-in-1 blood test to aid precision prostate cancer thera
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
A 3- in-1 blood test can predict which prostate cancer patients are provided more personalised precision therapies. Men with advanced prostate cancer who were likely to benefit from treatment with new drugs called PARP inhibitors were determined by testing cancer DNA in the bloodstream. The same test was used after starting treatment to see the response and to determine if a switch in treatment was required within 4-8 weeks. This test could be used to help doctors select treatment, check its effect and monitor cancer in the longer term...


http://bit.ly/2sKl3g6
Dr. s●●●●k t●●●●●r and 3 others like this
Like
Comment
Share